nytimes June 15, 2021 12:00pm The F.D.A.'s Approval of Biogen's Alzheimer's Drug Is a New Low #drugspharmaceuticals #aduhelmdrug #alzheimersdisease #foodanddrugadministration #biogeninc #news Opinion | The F.D.A. Has Reached a New Low The F.D.A.'s approval of the Alzheimer's drug aducanumab is inexplicable.
There are no comments yet.